David Steinhaus

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Diet and Lifestyle Recommendations Revision 2006

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

Long-term outcome following successful reopening of abrupt closure after coronary angioplasty

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators

Infective Endocarditis in Adults

Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Chronic inflammation in the etiology of disease across the life span

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

n–3 Fatty Acids in Cardiovascular Disease

Effects of Omega-3 Fatty Acids on Heart Rate in Cardiac Transplant Recipients††Disclaimer: Saint Luke’s Hospital holds a minority interest in OmegaMetrix, LLC, Kansas City, Missouri, a company offering blood omega-3 fatty acid testing.

Systematic Direct Angioplasty and Stent-Supported Direct Angioplasty Therapy for Cardiogenic Shock Complicating Acute Myocardial Infarction: In-Hospital and Long-Term Survival

Drotrecogin Alfa (Activated) in Adults with Septic Shock

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

Percutaneous Repair or Surgery for Mitral Regurgitation

Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases

Usefulness of B-type Natriuretic Peptide Levels in Predicting Hemodynamic and Clinical Decompensation

A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

Trends in Heart Failure Incidence and Survival in a Community-Based Population

Fish Intake, Contaminants, and Human Health

Myocarditis

The Role of Fish Oil in Arrhythmia Prevention

Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man

Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

n‐3 (omega‐3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling

Endocarditis-Associated Paravalvular Abscesses

Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>

Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Antiarrhythmic Effects of Omega-3 Fatty Acids

Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment

Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

The pathophysiology of acute heart failure—Is it all about fluid accumulation?

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

Omega-3 Fatty Acids for Cardioprotection

Dietary Fish and n-3 Fatty Acid Intake and Cardiac Electrocardiographic Parameters in Humans

Omega-3 Fatty Acids and Cardiovascular Disease

n−3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review

Infective endocarditis

Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction

Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction

Cardiovascular benefits of omega-3 fatty acids

Perivalvular Ectension of Infection in Patients with Infectious Endocarditis

Myocarditis

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Patient Selection Criteria and Management Guidelines for Outpatient Parenteral Antibiotic Therapy for Native Valve Infective Endocarditis

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Serum Long-Chain n-3 Polyunsaturated Fatty Acids and Risk of Hospital Diagnosis of Atrial Fibrillation in Men

The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases

Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

Air Pollution and Cardiovascular Disease

Introduction to the Analysis of Survival Data in the Presence of Competing Risks

Guidelines for percutaneous transluminal coronary angioplasty

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Racial Variation in Cardiac Procedure Use and Survival Following Acute Myocardial Infarction in the Department of Veterans Affairs

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Targeting G _βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Forecasting the Future of Cardiovascular Disease in the United States

Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity

Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Contemporary Definitions and Classification of the Cardiomyopathies

Critical Analysis of Coronary Artery Bypass Graft Surgery: A 30-Year Journey

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).

n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors

Particulate Matter Air Pollution and Cardiovascular Disease

2015 ESC Guidelines for the management of infective endocarditis

Analysis of prehospital delay among inner-city patients with symptoms of myocardial infarction: implications for therapeutic intervention.

Right Heart Pressure Increases after Acute Increases in Ambient Particulate Concentration

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction

Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study

Survival Methods

The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis

Ongoing right ventricular hemodynamics in heart failure

Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction

Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter, 12-month follow-up study of patients with chronic heart failure

Cardiac conduction abnormalities complicating native valve active infective endocarditis

Effects of Omega-3 Fatty Acids on Resting Heart Rate, Heart Rate Recovery After Exercise, and Heart Rate Variability in Men With Healed Myocardial Infarctions and Depressed Ejection Fractions

Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake